Sanofi Launches 2025 Global Employee Stock Purchase Plan Paris, June 5, 2025. Sanofi’s global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries. Now in its 11th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s growth and results. In 2024 alone, more than 32,000 Sanofi employees – 40% of the total workforce, chose to invest in the company through the program. Today, nearly 90,000 current or former Sanofi employees are shareholders, and hold approximately 2.55%1 of its capital. Paul HudsonChief Executive Officer of Sanofi“The Board of Directors and I are particularly proud to see the growing participation of our employees in our global employee shareholder plan, a commitment that has endured...

ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2025 Annual General Meeting held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:00 p.m. CEST / 9:00 a.m. EDT. The Company’s shareholders approved all agenda items. The shareholders approved the 2024 Annual Report including the 2024 Annual (Statutory) Financial Statements and the 2024 Consolidated Financial Statements. The shareholders acknowledged that on a standalone statutory financial statement basis, the Company incurred a loss of CHF 5,179,000 with respect to the financial year ended December 31, 2024, and resolved that the accumulated balance sheet loss of CHF 46,577,000 shall be carried forward to the new accounts. The members of the...

Transaction finalized with issuance of 125,000 preferred MEME Coin shares; token transfer confirmed on BSCScan Mesquite, June 05, 2025 (GLOBE NEWSWIRE) — June 5, 2025 – Mesquite, NV — Dogecoin Cash Inc. (OTC: CBDS) announced today that its wholly owned subsidiary, MEME Coins Inc., has successfully closed the acquisition of 1 billion DogeCoin Cash (CRYPTO:DOG) from Tipestry Inc., a social blockchain company. The transaction, which was completed yesterday, involved the issuance of 125,000 preferred shares of MEME Coins Inc., under a revised agreement from the originally proposed 500,000 shares. “This marks a major milestone in MEME Coins Inc.’s strategy to secure high-value digital assets as we build out our blockchain-based ecosystem,” said a CBDS company representative. “DOG tokens have the potential to be a strong utility and...

Dassault Aviation partners with Tata Advanced Systems to manufacture Rafale fighter aircraft fuselage for India and other global marketsFirst-ever Rafale fuselage production in India Dedicated manufacturing facility to be set up in Hyderabad(Saint-Cloud, Mumbai, June 5, 2025) – Dassault Aviation and Tata Advanced Systems Limited have signed four Production Transfer Agreements to manufacture the Rafale fighter aircraft fuselage in India, marking a significant step forward in strengthening the country’s aerospace manufacturing capabilities and supporting global supply chains. This facility represents a significant investment in India’s aerospace infrastructure and will serve as a critical hub for high-precision manufacturing. Under the scope of the partnership, Tata Advanced Systems will set up a cutting-edge production facility...

UAB “Kvartalas”, legal entity code 305475438, with its registered address at Jogailos St. 4, Vilnius, Republic of Lithuania (the Issuer), announces that, due to sufficient investor demand, the Issuer has decided to end the subscription process for the offering of the 3rd tranche of bonds (ISIN LT0000411167), effective as of the time of this announcement. New subscription orders are no longer accepted. As of the time of this announcement, Nasdaq Exchange Members shall not accept any new subscription orders from investors. By 12:00 midday today (5 June 2025) the Members may only enter into the Exchange Trading System previously received buy orders that have not yet been entered. Any orders entered into the Exchange Trading System after 12:00 will not be processed and will not be eligible for bond allocation. Please note that the results...

                                                                Press Release Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025 Paris, France – 5 June, 2025 – Atos, the Official Information Technology Partner of UEFA National Team Football, will deliver key IT services and applications support for the UEFA Nations League Finals™(UNLF) 2025, taking place from June 4 to June 8, 2025, in Germany. Atos’ expertise will once again support hundreds of millions of fans worldwide to share the electrifying experience of one of the highest profile football tournaments. To provide the best experience for all stakeholders, from the European football family to fans and media, Atos will be responsible for managing core IT planning and operations systems all requiring the highest level of reliability,...

HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”), today announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets. Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up...

HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”), today announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets. Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars,...

5 JUNE 2025  RICHEMONT PUBLISHES FY25 ANNUAL REPORT AND NON-FINANCIAL REPORT Richemont has today published its combined Annual Report and Accounts with the Business review, the Compensation Report and the Corporate Governance Report, along with its Non-Financial Report, for the year ended 31 March 2025. The Annual Report and Accounts, which includes the Chairman’s review to shareholders, the annual consolidated and statutory financial statements, and the corresponding audit reports was already published on 16 May 2025. The Non-Financial Report 2025, prepared in accordance with the Global Reporting Initiative (GRI) Standards (2021), provides Richemont’s disclosures on non-financial matters. The report complies with the reporting disclosure required by Articles 964a-c of the Swiss Code of Obligations, including the Swiss Ordinance...

Ageas Re partners with Slovenian insurer Triglav Group in connection with the Motor insurance business distributed by Italian Insurtech Prima Today, Ageas Re, the reinsurance arm of Ageas Group, concluded a reinsurance agreement with Slovenian insurer Triglav Group in connection with the partnership entered into by Triglav Group with leading Italian direct Motor insurance distributor, Prima Assicurazioni S.p.A. (Prima), with the objective to expand its business portfolio and to contribute to the Ageas’s Elevate27 profitable growth ambitions. Under to the agreement, Ageas Re takes an 80% Quota Share on the Prima business underwritten by Triglav Group in 2025, commencing in the coming weeks. Prima is a rapidly growing, profitable insurance distributor that began distributing personal lines policies, mainly Motor, in 2015. Since then, it...